Cargando…
Tailored Cytokine Optimization for ex vivo Culture Platforms Targeting the Expansion of Human Hematopoietic Stem/Progenitor Cells
Umbilical cord blood (UCB) has been established as an alternative source for hematopoietic stem/progenitor cells (HSPC) for cell and gene therapies. Limited cell yields of UCB units have been tackled with the development of cytokine-based ex vivo expansion platforms. To improve the effectiveness of...
Autores principales: | Branco, André, Bucar, Sara, Moura-Sampaio, Jorge, Lilaia, Carla, Cabral, Joaquim M. S., Fernandes-Platzgummer, Ana, Lobato da Silva, Cláudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729524/ https://www.ncbi.nlm.nih.gov/pubmed/33330414 http://dx.doi.org/10.3389/fbioe.2020.573282 |
Ejemplares similares
-
Extracellular Vesicles Derived From Adult and Fetal Bone Marrow Mesenchymal Stromal Cells Differentially Promote ex vivo Expansion of Hematopoietic Stem and Progenitor Cells
por: Ghebes, Corina A., et al.
Publicado: (2021) -
Successful Use of Human AB Serum to Support the Expansion of Adipose Tissue-Derived Mesenchymal Stem/Stromal Cell in a Microcarrier-Based Platform
por: Moreira, Francisco, et al.
Publicado: (2020) -
Corrigendum: Successful Use of Human AB Serum to Support the Expansion of Adipose Tissue-Derived Mesenchymal Stem/Stromal Cell in a Microcarrier-Based Platform
por: Moreira, Francisco, et al.
Publicado: (2020) -
Influence of Culture Conditions on Ex Vivo Expansion of T Lymphocytes and Their Function for Therapy: Current Insights and Open Questions
por: Sudarsanam, Harish, et al.
Publicado: (2022) -
Improving the ex vivo expansion of human tumor-reactive CD8 + T cells by targeting toll-like receptors
por: Qiu, Chenli, et al.
Publicado: (2022)